Skip to main content

XenoTech to Use Waters Synapt HDMS System for Metabolomics Services

NEW YORK (GenomeWeb News) - Waters said today that XenoTech, a contract research organization based in Lenexa, Kan., has purchased a Waters Synapt High Definition Mass Spectrometry system.

XenoTech is using the system to provide metabolite profiling services, Waters said.

The CRO is using the Synapt, in combination with a Waters Acquity UltraPerformance Liquid Chromatograph, to provide its clients with in vitro drug metabolism study data.

Waters said that XenoTech purchased the Synapt system after an "exhaustive six-month evaluation of the offerings of all commercial instrument providers."

Financial terms of the agreement were not provided.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.